Adcendo Secures $75 Million in Series C Financing for Innovative ADC Pipeline Adcendo ApS has successfully closed a $75 million Series C funding round to support groundbreaking ADC treatments for cancer. This investment will enable significant advancements in their clinical pipeline.

Adcendo Secures $75 Million in Series C Financing for Innovative ADC Pipeline #Denmark #Copenhagen #Adcendo #ADC #Jeito_Capital